Status:
RECRUITING
Clinical Efficacy and Mechanism of tDCS for Dysphagia in PD
Lead Sponsor:
Wang Ping
Conditions:
Parkinson's Disease and Parkinsonism
Dysphagia
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
This study aims to verify transcranial direct current stimulation(tDCS) efficacy for Parkinson's disease (PD)-related dysphagia and its mechanism. Subjects are randomly split into two groups: control ...
Detailed Description
This study aims to verify the efficacy of tDCS in treating dysphagia in PD and explore its mechanism. Subjects are randomly divided into two groups: the control group receives sham tDCS as well as the...
Eligibility Criteria
Inclusion
- Meet the Chinese Diagnostic Criteria for Parkinson's Disease (2016) or MDS Diagnostic Criteria for Multiple System Atrophy or Progressive Supranuclear Palsy;
- VFSS examination indicates dysphagia;
- Mini-Mental State Examination (MMSE) score \>23;
- Willing to cooperate with the study and sign the informed consent form;
Exclusion
- Comorbid with other diseases that cause dysphagia;
- Comorbid with pneumonia, or severe cardiac/renal insufficiency;
- Having metal implants in the body
- With cognitive impairment or inability to cooperate.
Key Trial Info
Start Date :
July 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2030
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT07153692
Start Date
July 17 2025
End Date
March 31 2030
Last Update
September 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310000